Journal of Advance Research in Medical & Health Science (ISSN 2208-2425),
Journal Year:
2024,
Volume and Issue:
10(2), P. 100 - 104
Published: Feb. 10, 2024
Aging
is
a
risk
factor
for
various
chronic
diseases
such
as
diabetes,
dyslipidemia,
metabolic,
neurological,
and
cardiovascular
disease,
other
age-related
disorders.
Nicotinamide
mononucleotide
(NMN)
one
of
the
endogenous
intermediate
molecules
in
nicotinamide
adenine
dinucleotide
(NAD)
biosynthesis,
its
biological
function
known
to
be
related
an
increase
NAD
concentration.
levels
decline
are
critical
human
health
longevity.
The
material
methods
using
systematic
review
RCT,
with
participants
healthy
adults
aged
between
20-65
years
old,
agreed
take
NMN
supplementation
compared
Placebo.
inclusion
criteria
RCT
studies
regarding
administration
outcome
prevent
aging
primary
objective
measurement
blood
Trial
quality
was
assessed
JBI
checklist.
We
included
six
average
duration
intervention
10-12
weeks
dosage
250-900mg/day.
All
showed
that
can
significantly
improve
concentration
cause
only
mild
adverse
effects
during
trial.
In
conclusion,
has
significant
clinical
impact
preventing
adult
aging.
Aging Cell,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: July 9, 2023
Abstract
The
geroscience
hypothesis
proposes
that
addressing
the
biology
of
aging
could
directly
prevent
onset
or
mitigate
severity
multiple
chronic
diseases.
Understanding
interplay
between
key
aspects
biological
hallmarks
is
essential
in
delivering
promises
hypothesis.
Notably,
nucleotide
nicotinamide
adenine
dinucleotide
(NAD)
interfaces
with
several
aging,
including
cellular
senescence,
and
changes
NAD
metabolism
have
been
shown
to
be
involved
process.
relationship
senescence
appears
complex.
On
one
hand,
accumulation
DNA
damage
mitochondrial
dysfunction
induced
by
low
+
can
promote
development
senescence.
other
state
occurs
during
may
inhibit
SASP
as
this
secretory
phenotype
are
both
highly
metabolically
demanding.
However,
date,
impact
on
progression
has
not
fully
characterized.
Therefore,
explore
implications
replacement
therapies,
it
consider
their
interactions
We
propose
a
comprehensive
understanding
boosting
strategies
senolytic
agents
necessary
advance
field.
Phytomedicine,
Journal Year:
2024,
Volume and Issue:
129, P. 155665 - 155665
Published: April 28, 2024
Aging
is
the
primary
risk
factor
of
most
chronic
diseases
in
humans,
including
cardiovascular
diseases,
osteoporosis
and
neurodegenerative
these
extensively
damage
quality
life
for
elderly
individuals.
a
multifaceted
process
with
numerous
factors
influencing
it.
Efficient
model
organisms
are
essential
research
development
anti-aging
agents,
particularly
while
investigating
pharmacological
mechanisms.
This
review
discusses
application
Caenorhabditis
elegans
studying
aging
its
related
signaling
pathways,
presents
an
overview
studies
exploring
mechanism
screening
agents
C.
elegans.
Additionally,
summarizes
clinical
trials
to
inspire
new
medications.
Literature
was
searched,
analyzed,
collected
using
PubMed,
Web
Science,
Science
Direct.
The
search
terms
used
were
"anti-aging",
"medicinal
plants",
"synthetic
compounds",
"C.
elegans",
"signal
pathway",
etc.
Several
combinations
keywords
used.
Studies
conducted
or
humans
included.
Articles
excluded,
if
they
on
silico
vitro
could
not
offer
effective
data.
Four
compounds
mainly
derived
through
synthesis
(metformin,
rapamycin,
nicotinamide
mononucleotide,
alpha-ketoglutarate)
four
active
ingredients
chiefly
obtained
from
plants
(resveratrol,
quercetin,
Astragalus
polysaccharide,
ginsenosides)
introduced
emphatically.
These
exhibit
potential
effects
preclinical
studies.
investigation
their
mechanisms
can
benefit
use
Medicinal
provide
valuable
resource
treating
diseases.
A
wide
source
raw
materials
particular
plant
medicinal
having
meet
diverse
pharmaceutical
requirements,
such
as
immunomodulatory,
anti-inflammation
alleviating
oxidative
stress.
possesses
advantages
scientific
short
cycle,
small
size,
easy
maintenance,
genetic
tractability
conserved
biological
processes
aging.
be
efficient
rapid
evaluation
slow
down
Molecular Carcinogenesis,
Journal Year:
2024,
Volume and Issue:
63(4), P. 577 - 588
Published: Jan. 10, 2024
Abstract
Hepatocellular
carcinoma
(HCC)
is
a
common
malignancy
worldwide.
Herein,
we
investigated
the
role
of
nicotinamide
mononucleotide
(NMN)
in
HCC
progression.
cells
were
treated
with
NMN
(125,
250,
and
500
μM),
then
adenine
dinucleotide
(NAD
+
)
NADH
levels
measured
to
calculate
NAD
/NADH
ratio.
Cell
proliferation,
apoptosis,
autophagy
ferroptosis
determined.
AMPK
was
knocked
down
confirm
involvement
AMPK/mTOR
signaling.
Furthermore,
tumor‐inhibitory
effect
xenograft
models.
Exposure
dose‐dependently
increased
level
ratio
cells.
After
treatment,
cell
proliferation
inhibited,
whereas
apoptosis
enhanced
both
lines.
Additionally,
autophagy/ferroptosis
activated
pathway
knockdown
partially
rescued
effects
vitro.
treatment
restrained
tumor
growth
nude
mice,
autophagy/ferroptosis,
promoted
necrosis
tissues.
The
results
indicate
that
inhibits
progression
by
inducing
via
may
serve
as
promising
agent
for
treatment.
Aging and Disease,
Journal Year:
2025,
Volume and Issue:
unknown, P. 0 - 0
Published: Jan. 1, 2025
Age-related
diseases
have
emerged
as
a
global
concern
the
population
ages.
Consequently,
understanding
underlying
causes
of
aging
and
exploring
potential
anti-aging
interventions
is
imperative.
In
females,
ovaries
serve
principal
organs
responsible
for
ovulation
production
female
hormones.
The
are
related
to
infertility,
menopause,
associated
menopausal
syndromes,
with
menopause
representing
culmination
ovarian
aging.
Current
evidence
indicates
that
may
contribute
dysfunction
across
multiple
organ
systems,
including,
but
not
limited
to,
cognitive
impairment,
osteoporosis,
cardiovascular
disease.
Nevertheless,
due
widespread
distribution
sex
hormone
receptors
throughout
body,
affects
only
these
specific
also
influences
broader
spectrum
age-related
in
women.
Despite
this,
impact
on
overall
has
been
largely
neglected.
This
review
provides
thorough
summary
diseases,
encompassing
nervous,
circulatory,
locomotor,
urinary,
digestive,
respiratory,
endocrine
systems.
Additionally,
we
outlined
prospective
therapeutic
approaches
addressing
both
aim
mitigating
their
impacts
preserving
women's
fertility,
physical
health,
psychological
well-being.
Endocrine Journal,
Journal Year:
2024,
Volume and Issue:
71(2), P. 153 - 169
Published: Jan. 1, 2024
Obesity
and
aging
are
major
risk
factors
for
several
life-threatening
diseases.
Accumulating
evidence
from
both
rodents
humans
suggests
that
the
levels
of
nicotinamide
adenine
dinucleotide
(NAD+),
a
regulator
many
biological
processes,
declines
in
multiple
organs
tissues
with
obesity.
Administration
an
NAD+
intermediate,
mononucleotide
(NMN),
replenishes
intracellular
mitigates
aging-
obesity-associated
derangements
animal
models.
In
this
human
clinical
study,
we
aimed
to
investigate
safety
effects
8-week
oral
administration
NMN
on
biochemical,
metabolic,
ophthalmologic,
sleep
quality
parameters
as
well
chronological
alterations
content
peripheral
tissues.
An
8-week,
single-center,
single-arm,
open-label
trial
was
conducted.
Eleven
healthy,
middle-aged
Japanese
men
received
two
125-mg
capsules
once
daily
before
breakfast.
The
supplementation
regimen
well-tolerated;
blood
mononuclear
cells
increased
over
course
administration.
participants
insulin
oversecretion
after
glucose
loading,
modestly
attenuated
postprandial
hyperinsulinemia,
factor
coronary
artery
disease
(n
=
3).
conclusion,
overall
safely
effectively
boosted
biosynthesis
men,
showing
its
potential
alleviating
hyperinsulinemia.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Aug. 30, 2024
Nicotinamide
mononucleotide
(NMN),
a
crucial
intermediate
in
NAD
+
synthesis,
can
rapidly
transform
into
within
the
body
after
ingestion.
NMN
plays
pivotal
role
several
important
biological
processes,
including
energy
metabolism,
cellular
aging,
circadian
rhythm
regulation,
DNA
repair,
chromatin
remodeling,
immunity,
and
inflammation.
has
emerged
as
key
focus
of
research
fields
biomedicine,
health
care,
food
science.
Recent
years
have
witnessed
extensive
preclinical
studies
on
NMN,
offering
valuable
insights
pathogenesis
age-
aging-related
diseases.
Given
sustained
global
interest
substantial
market
expectations
for
future,
here,
we
comprehensively
review
milestones
biotherapy
over
past
10
years.
Additionally,
highlight
current
field
digestive
system
diseases,
identifying
existing
problems
challenges
research.
The
overarching
aim
this
is
to
provide
references
further
exploration
spectrum
The Journals of Gerontology Series A,
Journal Year:
2023,
Volume and Issue:
78(12), P. 2435 - 2448
Published: April 17, 2023
Abstract
Advancing
age
and
many
disease
states
are
associated
with
declines
in
nicotinamide
adenine
dinucleotide
(NAD+)
levels.
Preclinical
studies
suggest
that
boosting
NAD+
abundance
precursor
compounds,
such
as
riboside
or
mononucleotide,
has
profound
effects
on
physiological
function
models
of
aging
disease.
Translation
these
compounds
for
oral
supplementation
humans
been
increasingly
studied
within
the
last
10
years;
however,
clinical
evidence
raising
concentrations
can
improve
is
unclear.
The
goal
this
review
was
to
synthesize
published
literature
chronic
precursors
healthy
age-related
diseases.
We
identified
riboside,
co-administered
pterostilbene,
mononucleotide
most
common
candidates
investigations
NAD+-boosting
improving
humans.
Studies
have
performed
generally
midlife
older
adults,
adults
cardiometabolic
risk
factors
overweight
obesity,
numerous
patient
populations.
Supplementation
safe,
tolerable,
increase
related
metabolites
multiple
tissues.
Dosing
regimens
study
durations
vary
greatly
across
interventions,
small
sample
sizes
limit
data
interpretation
outcomes.
Limitations
future
research
directions
suggested
further
our
understanding
potential
efficacy
extending
human
health
span.
Cold Spring Harbor Perspectives in Medicine,
Journal Year:
2023,
Volume and Issue:
14(1), P. a041193 - a041193
Published: Oct. 17, 2023
Sofie
Lautrup1,6,
Yujun
Hou2,6,
Evandro
F.
Fang1,3
and
Vilhelm
A.
Bohr4,5
1Department
of
Clinical
Molecular
Biology,
University
Oslo
Akershus
Hospital,
1478
Lørenskog,
Norway
2Institute
for
Regenerative
Medicine,
Shanghai
East
Frontier
Science
Center
Stem
Cell
Research,
Key
Laboratory
Signaling
Disease
School
Life
Sciences
Technology,
Tongji
University,
200092,
China
3The
Norwegian
Centre
on
Healthy
Ageing
(NO-Age),
Oslo,
4DNA
Repair
Section,
National
Institute
Aging,
Institutes
Health,
Baltimore,
Maryland
21224,
USA
5Danish
Copenhagen,
2200
Denmark
Correspondence:
e.f.fang{at}medisin.no;
vbohr{at}sund.ku.dk